Shownotes
Incorporated on October 28, 2013, as a Swiss stock corporation (Aktiengesellschaft) under the name Inception Genomics AG (renamed CRISPR Therapeutics AG on April 28, 2014) and headquartered at Baarerstrasse 14 in Zug, Switzerland, with primary research and development operations in Boston and Framingham, Massachusetts, CRISPR Therapeutics AG is a commercial-stage biotechnology company developing transformative gene-based medicines21. Although domiciled in Switzerland, the company files domestic U.S. GAAP periodic reports (Forms 10-K, 10-Q, and 8-K) with the U.S. Securities and Exchange…
Website: rss.com

